Home › Funds › Oxbow Advisors, LLC › JNJ

Oxbow Advisors, LLC position in JNJ

JOHNSON & JOHNSON · Health Care

Oxbow Advisors, LLC reported holding 45,889 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$12.1M, representing 0.88% of its reported portfolio and ranking #23 among its reported holdings. Oxbow Advisors, LLC has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)45.89K sh
Reported value held$12.15M
Portfolio Weight0.88%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Oxbow Advisors, LLC's JNJ position evolved

Oxbow Advisors, LLC first disclosed a stake in JNJ in Q3 2023 at 8,612 shares (US$1.3M). The position peaked in Q3 2026 at 45,889 shares, worth US$12.1M. Across 13 filings, Oxbow Advisors, LLC increased the stake 10 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 45,889 shares valued at US$12.1M — an increase of 633 shares quarter over quarter.. Notable position changes include a 340% increase in Q4 2023 (shares rose 1% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 8.61K $1.34M New
Q4 2023 37.89K $5.94M Add
Q1 2024 39.49K $6.25M Add
Q2 2024 39.85K $5.82M Add
Q3 2024 41.32K $6.70M Add
Q4 2024 41.54K $6.01M Add
Q1 2025 43.41K $7.20M Add
Q2 2025 44.66K $6.82M Add
Q3 2025 45.30K $8.40M Add
Q4 2025 44.95K $9.30M Reduce
Q1 2026 44.22K $10.81M Reduce
Q2 2026 45.26K $11.49M Add
Q3 2026 45.89K $12.15M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Oxbow Advisors, LLC held JNJ?

Oxbow Advisors, LLC has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Oxbow Advisors, LLC's current position in JNJ?

As of Q3 2026, Oxbow Advisors, LLC holds 45.89K shares of JNJ (JOHNSON & JOHNSON), valued at $12.15M, representing 0.88% of its reported portfolio and ranking #23.

Has Oxbow Advisors, LLC been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Oxbow Advisors, LLC increased its position in JNJ. The position peaked in Q3 2026 at 45.89K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.